Stockwinners Market Radar for March 12, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:01 EST MoneyGram to suspend services in Russia - MoneyGram International issued the following statement: "We have been closely monitoring the situation in Ukraine with great concern for all those impacted. As the humanitarian crisis in the region continues to escalate, we are providing notice to our customers and agents of our decision to suspend services in Russia. We join many voices in expressing our hope for a swift and peaceful resolution to protect civilians across all impacted regions and will continue to assess the situation. Our top priority remains the safety of our employees, agents, partners, and their families. We have been in close contact with our impacted colleagues to provide support during this difficult time. We have also increased our support for our partnership with Save the Children, which is actively engaged in relief efforts in the region. Last week, the MoneyGram Foundation approved an emergency grant directed towards the Ukrainian Relief Fund. MoneyGram services remain available in Ukraine - both for individuals to receive funds in-person or digitally directly to their bank account. Every day we see more transactions sent to Ukraine and surrounding countries such as Poland as customers transfer money to their families who are increasingly in need during this crisis."

18:14 EST Patterson-UTI CFO Smith sells 50,000 common shares - In a regulatory filing, Patterson-UTI CFO Charles Andrew Smith disclosed the sale of 50,000 common shares of the company on March 10 at a price of $16.20 per share.

18:02 EST Electric Last Mile Solutions announces SEC probe - In a regulatory filing, the company said, "On March 7, 2022, the company learned that the Division of Enforcement of the Securities and Exchange Commission is conducting an investigation involving the matters discussed in Current Reports on Form 8-K filed by the company on September 27, 2021, February 1, 2022 and February 14, 2022 and Exhibits 99.1 and 99.2 to Forum Merger III Corporation's Current Report on Form 8-K filed on March 16, 2021. The company intends to cooperate fully with the SEC investigation. At this point, the company cannot predict the eventual scope, duration or outcome of this matter."

17:56 EST Olympic Steel senior advisor Wolfort sells 45,351 common shares - In a regulatory filing, Olympic Steel senior advisor David Wolfort disclosed the sale of 45,351 common shares of the company on March 10 at a price of $30.99 per share.

17:32 EST Uber rolls out temporary fuel surcharge - Uber said that it is rolling out a temporary fuel surcharge. Beginning Wednesday, March 16, consumers will pay a surcharge of either 45c or 55c on each Uber trip and either 35c or 45c on each Uber Eats order, depending on their location-with 100% of that money going directly to workers' pockets. The surcharges are based off the average trip distance and the increase in gas prices in each state. This is temporary for at least the next 60 days, when the company will reassess. "We know that prices have been going up across the economy, so we've done our best to help drivers and couriers without placing too much additional burden on consumers," the company said. "Over the coming weeks we plan to listen closely to feedback from consumers, couriers and drivers. We'll also continue to track gas price movements to determine if we need to make additional changes." Reference Link

17:19 EST SBA Communications EVP Bagwell sells over 3,000 class A common shares - In a regulatory filing, SBA Communications EVP Kurt Bagwell disclosed the sale of 3,757.382 class A common shares of the company on March 9 at a price of $330 per share.

16:55 EST Marsh McLennan appoints Katherine Brennan as general counsel - Marsh McLennan announced the appointment of Katherine Brennan as senior VP and general counsel. She will report to Dan Glaser, president and CEO of Marsh McLennan, and will join the company's executive committee. The appointment is effective immediately. She succeeds Peter Beshar, who has served as the company's executive VP and general counsel since 2004. Last fall, Beshar was nominated by President Biden to serve as the general counsel of the U.S. Department of the Air Force. Yesterday, the U.S. Senate unanimously confirmed his nomination.

16:46 EST PG&E, Ford collaborate on bidirectional EV charging technology - Pacific Gas and Electric Company (PCG) and Ford Motor Company (F) announced a collaboration exploring how Ford's new F-150 Lightning electric vehicle-the first commercially available light-duty truck with bidirectional charging technology-can interact with the electric grid and provide electric reliability benefits to PG&E customers. One in five EVs in the country are on the road in PG&E's service area of Northern and Central California, where customers are often early adopters of new clean energy technologies. PG&E and Ford will test the F-150 Lightning and its Intelligent Backup Power bidirectional charging capabilities in providing backup power for customers' homes in PG&E's service area. Intelligent Backup Power, making its debut on the F-150 Lightning, gives customers the ability to use bidirectional power technology from their all-electric truck to provide up to 10 days of power to their homes during an outage, depending on home energy usage. The first installations of Ford's Intelligent Backup Power are beginning in spring 2022, supported by Sunrun as Ford's preferred installation partner. Through this early adopter opportunity, PG&E will explore how Ford's Intelligent Backup Power technology interconnects to the electric grid, which is necessary for the truck's battery to power the home, and how it can support customer resiliency during grid outages. Additionally, PG&E expects to learn more about the overall customer experience to help inform future collaborations as this emerging technology becomes more readily available. "Today, we are seeing breakthrough opportunities at the intersection of the energy and transportation industries. As more electric vehicles and new charging technology become available, it is critical that we better understand how EVs can interact with the electric grid and how we can best support our customers. Through collaborations with automakers like Ford, we are innovating together for a cleaner, safer and brighter future for all," said PG&E Corporation CEO Patti Poppe.

16:31 EST Tattooed Chef to restate 2021 quarterly financial statements - Tattooed Chef announced that it will restate prior period financial statements for each of the quarterly periods ended March 31, 2021, June 30, 2021 and September 30, 2021 because the company did not properly record the tax effects associated with the company's issuance of 825,000 shares of its common stock to Harrison Co. in June 2021 as partial consideration for services rendered in connection with the company's de-SPAC transaction that occurred in October 2020. The $4M deferred tax asset that should have been recorded as of December 31, 2020 was determined to have an immaterial impact on the company's consolidated financial statements as of and for the year ended December 31, 2020. However, the impact of this error, when combined with other immaterial error corrections for the quarter ended March 31, 2021, was determined to be material to the Company's consolidated balance sheet as of March 31, 2021. In June 2021, the company recorded a full valuation allowance on all of its deferred tax assets. Accordingly, the increase in the valuation allowance associated with this deferred tax asset was also deemed to be material to the company's results of operations for the three and six months ended June 30, 2021 and the nine months ended September 30, 2021. The company further expects that the restatements will have no effect on its future operations.

16:17 EST AstraZeneca receives FDA approval for Lynparza - AstraZeneca and MSD's Lynparza has been approved in the U.S. for the adjuvant treatment of patients with germline BRCA-mutated, or gBRCAm, HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery. The approval by the FDA was based on results from the OlympiA Phase III trial presented during the 2021 American Society of Clinical Oncology Annual Meeting and published in The New England Journal of Medicine.

16:11 EST Chico's appoints Kevin Mansell as next chair - Chico's announced that its board of directors has appointed Kevin Mansell as the next chair of the board, effective immediately following the company's 2022 annual meeting of shareholders. With Mansell's appointment, the chair of the board will again be an independent director. Mansell succeeds Bonnie Brooks, who has served as executive chair of the board since 2020 and will continue to serve as a director and a member of the merchant committee and executive committee.

16:06 EST Mimecast shareholders approve Permira transaction - Mimecast announced at the company's special meeting that its shareholders voted to approve the company's pending acquisition by funds advised by Permira. "I thank our shareholders for their strong support of this transaction and of Mimecast throughout our company's history," said Peter Bauer, chairman and chief executive officer of Mimecast. "With this significant milestone now behind us, we look forward to completing the transaction with Permira and delivering immediate and premium value to our shareholders. As a private company supported by Permira, we will be well positioned to continue to strengthen the cybersecurity and resilience of organizations around the world." Based on a preliminary tabulation of the shareholder vote, approximately 99.76% of votes cast were in favor of the proposed transaction, representing approximately 75.30% of all outstanding shares. The final voting results on the proposals voted on at the special meeting will be set forth in a Form 8-K filed by Mimecast with the U.S. Securities and Exchange Commission. Under the terms of the previously announced transaction, funds advised by Permira will acquire all outstanding ordinary shares of Mimecast for $80.00 per share in cash. The transaction is expected to close in the first half of 2022, subject to regulatory approvals. Upon completion of the transaction, Mimecast will become a privately held company and the ordinary shares of Mimecast will no longer be listed on any public market.

15:46 EST Bitfarms acquires land, building in Sherbrooke, Quebec - Bitfarms has acquired land and a building in Sherbrooke, Quebec. This new location, known as Garlock, is expected to have a power capacity of 18 megawatts and will replace the existing de la Pointe facility, which will eventually be retired as previously announced in the company's press release dated September 7, 2021. Farms in development increases from three to four. The total purchase price of the Garlock location consists of cash in the amount of C$2.25M and 25,000 common share purchase warrants. Each Warrant will entitle the holder thereof to purchase one common share of Bitfarms at a price of $3.47 for two years from the date of issuance. The new facility will benefit from Bitfarms' existing cost-effective contracts that supply green hydro power at an average cost of US four cents per kilowatt hour.

14:32 EST Deutsche Bank says in process of winding down remaining business in Russia - Deutsche Bank made the following statement on Russia: "As we have repeatedly said, we condemn the Russian invasion of Ukraine in the strongest possible terms and support the German government and its allies in defending our democracy and freedom. To clarify: Deutsche Bank has substantially reduced its Russian exposure since 2014. Like some international peers and in line with our legal and regulatory obligations, we are in the process of winding down our remaining business in Russia while we help our non-Russian multinational clients in reducing their operations. There won't be any new business in Russia." Reference Link

13:54 EST Electronic Arts' upcoming 'Dead Space' reboot out early 2023 - Electronic Arts said that its upcoming reboot of "Dead Space" has an arrival window of early 2023. Reference Link

13:46 EST YouTube blocks access to channels associated with Russian state-funded media - Alphabet's YouTube said that it is now removing content about Russia's invasion in Ukraine that violates its Community Guidelines policy that prohibits content denying, minimizing or trivializing well-documented violent events. "In line with that, we are also now blocking access to YouTube channels associated with Russian state-funded media globally, expanding from across Europe," the company said. "This change is effective immediately, and we expect our systems to take time to ramp up. Since our last update, our teams have now removed more than 1,000 channels and over 15,000 videos for violating not only our hate speech policy, but also our policies around misinformation, graphic content and more. Our systems are also connecting people to trusted news sources. So far, our breaking news and top news shelves on our homepage have received more than 17M views in Ukraine. In addition, we recently paused all YouTube ads in Russia. We've now extended this to all of the ways to monetize on our platform in Russia. Our teams continue to closely monitor the situation, and are ready to take further action. We will continue to share updates as they become available." Reference Link

13:00 EST Baker Hughes reports U.S. rig count up 13 to 663 rigs

12:48 EST Volkswagen says war in Ukraine may have negative impact - Volkswagen said, "However, this guidance is subject to the further development of the war in Ukraine and in particular the impact on the Group's supply chains and the global economy as a whole. At the time of preparing this outlook, there is a risk that the latest developments in the war in Ukraine will have a negative impact on the Volkswagen Group's business. This may also result from bottlenecks in the supply chain. At the present time, it is not yet possible to conclusively assess the specific effects. Nor is it possible at this stage to predict with sufficient certainty to what extent a potential further escalation of the war in Ukraine will impact on the global economy and growth in the industry in fiscal year 2022."

12:23 EST Eni, BP finalize agreement to create new independent JV in Angola - BP (BP) and Eni (E) confirmed that they have signed an agreement to form a new 50/50 independent company, Azule Energy, through the combination of the two companies' Angolan businesses. The agreement follows the memorandum of understanding between the companies agreed in May 2021. Azule Energy will be a new international energy company, independently managed, with more than 200,000 barrels equivalent a day of net oil and gas production and 2 billion barrels equivalent of net resources, the companies said in a statement, adding that it is expected to be Angola's largest producer, holding stakes in 16 licences, as well as participating in the Angola LNG joint venture. Azule Energy will also take over Eni's stake in Solenova, a solar company jointly held with Sonango, they said.

12:00 EST Lufax falls -24.7% - Lufax is down -24.7%, or -$1.46 to $4.42.

12:00 EST Nine Energy Service falls -25.9% - Nine Energy Service is down -25.9%, or -$1.09 to $3.14.

12:00 EST Tidewater rises 9.9% - Tidewater is up 9.9%, or $1.87 to $20.71.

11:32 EST Verso announces stockholder approval of merger agreement with BillerudKorsnas - Verso Corporation (VRS) announced that, at a special meeting of stockholders, its stockholders voted to approve the previously announced merger with BillerudKorsnas (BLRDF) as well as other related proposals. The merger proposal was supported by approximately 98.5% of votes cast, representing approximately 73% of outstanding shares of Verso's common stock. The final voting results of the special meeting, as tabulated by an independent inspector of elections, will be filed as part of a Form 8-K with the U.S. Securities and Exchange Commission. Verso and BillerudKorsnas now expect the merger to close in late-March or April of 2022, subject to the satisfaction of customary closing conditions, including the receipt of approvals from the Nuclear Regulatory Commission and the Public Service Commission of Wisconsin.

11:12 EST British American Tobacco taking steps to exit Russia, revises FY22 guidance - British American Tobacco issued the following Russia business update and revised guidance in a notice to the London Stock Exchange: "At BAT we pride ourselves on our values and our ethos. We join together as one company to call on all leaders and governments to find a peaceful and sustainable resolution to this tragic conflict through the power of dialogue and diplomacy. Building on our announcement of 9th March 2022, we have now completed the review of our presence in Russia. The context is highly complex, exceptionally fast-moving and volatile. We have concluded that BAT's ownership of the business in Russia is no longer sustainable in the current environment. Today, we have initiated the process to rapidly transfer our Russian business in full compliance with international and local laws. Beyond continuing to pay our 2,500 employees, we will do our utmost to safeguard their future employment. Upon completion, BAT will no longer have a presence in Russia. Following our decision today, and in light of the continuing uncertainty related to Ukraine and Russia and the possible indirect impact on the rest of the Group, we consider it prudent to revise our guidance for full year 2022. We now expect constant currency Group revenue growth of 2% to 4% and Mid-Single Figure constant currency adjusted diluted EPS growth. In 2021, Ukraine and Russia accounted for 3% of Group revenue and a slightly lower proportion of adjusted profit from operations."

11:05 EST U.S. video game spending fell 6% y/y in February, says NPD - NPD analyst Mat Piscatella said that February 2022 U.S. consumer spending across video game hardware, content and accessories fell 6% when compared to a year ago, to $4.4B. Declines were experienced across all major categories of spend, with hardware showing the largest YoY % decline. 2022 year-to-date spending is down 4% when compared to the same period a year ago, at $9.1B. Console hardware supply continues to be a market challenge. Total market spending when compared to a year ago has now declined for 4 consecutive months. Video game hardware dollar sales fell 27% when compared to February 2021, to $295M. Year-to-date dollar sales are 5% lower than a year ago, at $685M. The hardware market remains in a supply constrained state. The Nintendo Switch (NTDOY) was the best-selling hardware platform of February 2022 in both units and dollars. The Xbox Series (MSFT) ranked 2nd across both measures. The PlayStation 5 (SONY) leads video game hardware in 2022 dollar sales year-to-date, while Switch has achieved the highest unit sales in the period. Other publicly traded companies in the space include Activision Blizzard (ATVI), Electronic Arts (EA), GameStop (GME), Take-Two (TTWO), Tencent (TCEHY) and Ubisoft (UBSFY). Reference Link

11:02 EST Vertiv, Elea Digital enter strategic alliance for edge data center services - Elea Digital and Vertiv announce partnership to deliver edge data center services in Brazil. Vertiv will provide operation and maintenance services for Elea Digital data centers in key metro areas, including Porto Alegre, Curitiba, and Brasilia. Vertiv's local technicians will provide support for the edge services contract in Brazil. Through the partnership with Elea Digital, Vertiv will gain a larger and wider market to support the Brazilian data center industry growth. The partnership between Elea Digital and Vertiv aims at maintaining market growth rates across a continent-wide geographical footprint.

10:13 EST SES obtains BBB credit rating by Fitch - SES S.A. announced earlier that Fitch Ratings assigned a Long-Term Issuer Default Rating and senior unsecured rating of 'BBB' with a stable outlook. Fitch has also assigned SES's subordinated hybrid securities a rating of 'BB+'. The rating, according to Fitch, reflects SES's leading position in the global satellite sector, strong underlying free cash flow and financial flexibility. Sandeep Jalan, CFO of SES, commented, "We are delighted to initiate a rating with Fitch, which recognises SES's strong business profile. We are committed to maintaining a strong balance sheet while continuing to pursue our strategy to grow our footprint and leadership in the global satellite sector." Shares of SES are up 7.5% to $7.44 in morning trading.

10:00 EST PlayAGS falls -10.3% - PlayAGS is down -10.3%, or -81c to $7.06.

10:00 EST Tilly's falls -23.3% - Tilly's is down -23.3%, or -$2.85 to $9.40.

10:00 EST Valens Semiconductor rises 9.1% - Valens Semiconductor is up 9.1%, or 53c to $6.36.

09:47 EST PlayAGS falls -9.8% - PlayAGS is down -9.8%, or -77c to $7.10.

09:47 EST Tilly's falls -24.0% - Tilly's is down -24.0%, or -$2.94 to $9.30.

09:47 EST Valens Semiconductor rises 8.6% - Valens Semiconductor is up 8.6%, or 50c to $6.33.

09:35 EST LegalZoom trading resumes

09:24 EST MFA Financial announces $250M share repurchase program - MFA announced that its Board of Directors has authorized a share repurchase program under which MFA may repurchase up to $250M of its common stock through the end of 2023. The Board's authorization replaces the authorization under MFA's existing stock repurchase program that was adopted in November 2020, which had also authorized the company to repurchase up to $250M of its common stock and under which approximately $25.6M remained available for the repurchase of shares.

09:14 EST B. Riley Financial proposes to acquire Lazydays for $25.00 per share cash - In a letter to Lazydays CEO Robert DeVincenzi , Bryant Riley, Chairman, Co-CEO of B. Riley Financial stated, in part, "This non-binding letter is intended to summarize the principal terms of a proposal by B. Riley Financial or a subsidiary thereof regarding its possible acquisition of Lazydays Holdings. The possible acquisition of the outstanding capital stock of the company is referred to as the 'Transaction' and Buyer and the company are referred to collectively as the 'Parties.' As you know, we are one of the company's largest investors holding over one million shares of common stock. First, we want to thank you for initially meeting with us in January and for taking the time to hear our thoughts on the company's direction soon after the resignation of the company's longtime CEO and Chairman. We have also had constructive conversations with other board members. We acknowledge and support recent increases to the share buyback program, but note that the market continues to discount company's ability to grow. After significant analysis and diligence based on publicly available information, we have concluded that the company would be better served away from the glare of the public markets in an environment where the necessary investments in growth can be made without market fixation on short-term results. We are proposing a take-private transaction at a healthy premium to the current share price. The purchase price would be $25.00 per share payable in cash."

09:08 EST AT&T provides strategy update, financial outlook ahead of Discovery transaction - In anticipation of closing the pending WarnerMedia transaction with Discovery (DISCA) in the second quarter, AT&T (T) is laying out its updated strategy and financial outlook for the company moving forward. This includes detailed operational and financial expectations through 2023. As part of this strategy, AT&T plans to double its fiber footprint to 30-plus million locations, including increasing its business customer locations by 2x to 5 million. In doing so, the company expects to add 3.5M to 4M customer locations each year. The company also expects to enhance its 5G network by deploying 120 MHz of mid-band spectrum to cover more than 200M people by the end of 2023. Enabling faster speeds, increased capacity and lower latency, this valuable mid-band spectrum complements the company's existing 5G footprint, which covers more than 255M people in more than 16,000 cities and towns. By 2025, AT&T expects that 75% of its network footprint will be served via fiber and 5G and that it will have reduced its copper services footprint by 50%. At the same time, the company will successfully navigate the timing and profitability of the migration from legacy to next-generation products to optimize returns. The simultaneous ongoing shutdown of AT&T's copper services footprint with expansion of its fiber footprint will help drive cost savings while creating new revenue opportunities. AT&T is also focused on simplifying its business product portfolio, with plans to reduce the number of products and legacy rate plans by 50%. As a standalone company, AT&T will also continue to pursue its transformation initiatives and sees significant opportunities to optimize its cost structure. By the end of 2023, the company expects to reach $6B in run-rate cost savings. By the end of 2021, it had achieved more than $3B in cost savings, which were primarily reinvested into the company's growth engines. And in 2022 and 2023, AT&T expects an additional $2.5B in cumulative cost savings, which will increasingly fall to the bottom line, driving growth in adjusted EBITDA. AT&T will ramp investment to deploy fiber and 5G and drive sustainable earnings growth. In 2022, AT&T expects capital investment in the $24B range. The company expects 2023 capital investment to be similar to 2022 levels and then to begin to taper to the $20B range starting in 2024. As it moves through this investment cycle, the company expects several tailwinds to help drive sustainable returns: a recovery in international roaming revenues in wireless; subscriber growth in wireless and fiber following recent upfront investments in advertising and promotion; and tapering of transformation-related costs. Even as it steps up investment, AT&T expects to continue to deliver just over $8V in cash via annual total dividends to its shareholders after the close of the WarnerMedia-Discovery transaction. This represents a payout of about 40% against expected 2023 free cash flow in the $20B range. While the decision on AT&T's common dividend payout is always made by the board at the time each dividend is declared, given expectations that the WarnerMedia transaction will close in early second quarter, AT&T expects the May dividend to be paid according to the previously announced annual common dividend amount at $1.11 per share. AT&T continues to expect to use free cash flow after dividends to reduce its net debt to adjusted EBITDA ratio to the 2.5x range by the end of 2023.5 As it approaches this target, the company will have additional flexibility to consider share repurchases and increased success-based investments.

09:05 EST Bassett announces special, regular dividends, increase in share repurchase - Bassett Furniture Industries announced that its Board of Directors has: Declared a special dividend of $1.50 per share of common stock payable on April 6, 2022, to shareholders of record at the close of business on March 23, 2022. Declared a regular quarterly dividend of 14c per share of common stock payable on May 27, 2022, to shareholders of record at the close of business on May 13, 2022. Increased the Company's share repurchase authorization to $40M. "We are pleased that the Board of Directors has approved the declaration of a $1.50 special dividend and increased our share repurchase authorization to $40 million," said Rob Spilman, Chairman and CEO. "Although we are in uncertain times with increased fuel costs, rampant inflation, and the war in Ukraine, the housing market and home furnishings demand remain relatively strong. We will use our operating cash flow and our balance sheet to more aggressively invest in our business. Meanwhile, we will continue to be opportunistic with share repurchases while continuing to evaluate our capital allocation strategy."

09:03 EST Southern Missouri Bancorp announces executive leadership transition plan - Southern Missouri Bancorp, the parent corporation of Southern Bank, announced an executive leadership transition plan. On March 10, 2022, the Board of Directors of Southern Missouri Bancorp unanimously appointed Greg Steffens as Chairman of the Board, to succeed L. Douglas Bagby, effective July 1, 2022. Steffens will continue to serve as Chief Executive Officer of the Company, a role he has held since 1999. Bagby will continue to serve as a director, and he will also serve as Vice-Chairman and lead outside director for the Company. Additionally, the Board of Directors of Southern Bank unanimously appointed Steffens as Chairman of the Board, to succeed Sammy Schalk, also effective July 1, 2022. Schalk will continue to serve as a director and will serve as Vice-Chairman of the Bank. The Board of Directors of the Company further unanimously appointed Matthew Funke as President and Chief Administrative Officer, and the Board of Directors of the Bank unanimously appointed Funke as President and Chief Executive Officer; both effective July 1, 2022. The Board of Directors of the Bank also intends to appoint him as a director on that date. Funke is currently an Executive Vice President and Chief Financial Officer of the Company and the Bank. The Board also unanimously appointed Lora Daves as Executive Vice President and Chief Financial Officer, effective July 1, 2022. Daves is currently an Executive Vice President and Chief Risk Officer of the Company and the Bank, having served in that role since 2017. The Board further unanimously appointed Lance Greunke as Executive Vice President effective March 10, 2022, and as Chief Risk Officer, effective July 1, 2022. Greunke previously served as Secretary, Treasurer, and Chief Financial Officer of Fortune Financial Corporation.

09:02 EST WisdomTree announces ETF reverse share split - WisdomTree announced a reverse share split on the WisdomTree Floating Rate Treasury Fund. The reverse split decreases the number of shares outstanding and increases the price per share. The split will not change the total value of a shareholder's investment, except with respect to the redemption of fractional shares as described below. WisdomTree will execute the reverse split of the shares effective at the open of the market on March 24th, 2022. Please note that a CUSIP change will also become effective at the open of the market on March 24th, 2022.

09:01 EST Blue World Acquisition announces separate trading of shares, warrants, rights - Blue World Acquisition Corporation announced that, commencing on March 16, 2022, holders of the 9,200,000 units sold in the Company's initial public offering, including Units sold upon the full exercise of the underwriters' over-allotment option, may elect to separately trade the Class A ordinary shares, warrants, and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market under the symbol "BWAQU". Any underlying Class A ordinary shares, warrants, and rights that are separated are expected to trade on the NASDAQ under the symbols "BWAQ," "BWAQW," and "BWAQR," respectively. Holders of Units will need to have their brokers contact the Company's transfer agent, Continental Stock Transfer & Trust Company, in order to separate the holders' Units into Class A ordinary shares, warrants, and rights.

08:56 EST B. Riley Securities reports 8.6% stake in Lazydays, seeks talks on acquisition - B. Riley Securities purchased the common stock for investment purposes, and such purchases were made in the ordinary course of business. As with their other investments, B. Riley Securities continuously evaluates Lazydays and its businesses, results of operations, and prospects. In light of that evaluation, B. Riley Securities determined that Lazydays was not getting credit for its ability to grow and that it would be more successful with its growth initiatives as a private company without the focus on short term results. To that end, on March 9, 2022, BRF sent a non-binding letter to Lazydays outlining the principal terms on which BRF would be willing to acquire it, and is filing this Schedule 13D. B. Riley Securities intend to engage in discussions with Lazydays, its representatives, and other stakeholders concerning the letter and the proposal contained therein and to enter into negotiations. There can be no certainty those discussions will occur or, if they do, regarding the outcome of those discussions.

08:41 EST Warby Parker announces new partnership with Eastman Chemical - Warby Parker (WRBY) announced a new partnership with Eastman (EMN) to create a demo lens molecular recycling program. Since the summer of 2021, discarded demo lenses from Warby Parker's optical labs, located in Sloatsburg, New York, and Las Vegas, Nevada, have been sent to Eastman's facility in Kingsport, Tennessee, where Carbon Renewal Technology is used to break the lenses down to their molecular level. Once broken down, the molecules are reused as the building blocks to create Eastman Acetate Renew-an acetate exclusively supplied by Eastman that is 60% bio-based and 40% certified recycled content. Acetate Renew is chemically and physically identical to traditional acetate; it offers a sustainable solution with no compromise to aesthetics, durability, or performance. The brand plans to begin incorporating Acetate Renew into some of its frames later this year.

08:35 EST Safe-T partners with TerraZone, DreamVPS to launch Virtual Private Workforce - Safe-T Group announced that it has partnered with TerraZone and DreamVPS to offer a first-of-its-kind Virtual Private Workforce, VPW, cloud service. The new VPW cloud service was developed in response to organizational workforce shifts to remote or work-from-anywhere models accelerated by the COVID-19 pandemic and current geopolitical events. The VPW cloud service provides small and medium-sized businesses, SMBs, with a fully hosted and virtualized infrastructure designed to support the needs of software development teams. "We are excited about our new partnership and engagement with DreamVPS to provide a compelling new security solution to their large global customer base, adding to our continued revenue growth in 2022. VPW incorporates some of the best-of-breed security technologies, including our ZoneZero(R) network access solution, with the data protection technology by Safe-T and TerraZone, all delivered via DreamVPS' cloud platform. Together, we are enabling organizations to significantly enhance the security of their valuable R&D and intellectual property with an effective, easy-to-implement service," said Shachar Daniel, Chief Executive Officer of Safe-T.

08:33 EST Trust Stamp, VIVA Finance announce partnership focusing on financial inclusion - Trust Stamp announces a partnership with VIVA Finance, VIVA, a mobile-first FinTech lending platform. With a shared core focus on financial inclusion, Trust Stamp and VIVA are leveraging their solutions together to "support robust, accessible, and equitable financial systems as the foundation for global inclusion," the company said. Trust Stamp Chief Commercial Officer, Kinny Chan comments: "Trust Stamp's vision for global inclusion has driven our work to provide secure, privacy-first identity solutions for the billions of people around the world whose lack of verifiable data prevents them from accessing financial services. VIVA's transformative work highlights the need for equitable services and greater consumer choice even in highly developed economies. The integration of Trust Stamp's secure, equitable, and dignified solutions for establishing trust is an important factor in the multifaceted effort to empower all individuals with financial opportunity. We are thrilled to work with the VIVA team as we continue fostering mission-aligned partnerships to expand the reach and impact of Trust Stamp's powerful identity solutions."

08:29 EST Pearson says rejected 'preliminary and highly conditional' Apollo proposals - In a response issued to the London Stock Exchange, Pearson (PSO) noted the announcement made by Apollo Global (APO) and stated: "The Board of Pearson confirms that, on 5 November 2021, it received an unsolicited, preliminary and highly conditional proposal from Apollo regarding a possible cash offer for the entire issued and to be issued share capital of the company at 800 pence per share. The Board of Pearson considered the First Proposal, together with its financial and legal advisers, and concluded that it significantly undervalued the company and its future prospects, and accordingly unanimously rejected the First Proposal. On 7 March 2022, Pearson received a second unsolicited, preliminary and highly conditional proposal from Apollo regarding a possible cash offer for the entire issued and to be issued share capital of the company at 854.2 pence per share, including the FY 2021 dividend of 14.2 pence per share which has been announced but not yet paid. The Board of Pearson considered the Second Proposal, together with its financial and legal advisers, and concluded that it significantly undervalued the company and its future prospects. Accordingly, the Board of Pearson unanimously rejected the Second Proposal. The Board is confident that the lifelong learning strategy set out in March 2021 will create sustainable, long-term value for Pearson stakeholders and that the results for FY 2021 demonstrated the building momentum as Pearson executes on this new strategic vision. The Board is also mindful of its fiduciary duties in the event that an appropriate proposal is forthcoming. There can be no certainty that any offer will be made, nor as to the terms of any offer. In accordance with Rule 2.6(a) of the Code, Apollo is required, by no later than 5.00 pm on 8 April 2022, either to announce a firm intention to make an offer for Pearson in accordance with Rule 2.7 of the Code or to announce that it does not intend to make an offer for Pearson, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code. This announcement has been made without the consent of Apollo."

08:22 EST Global Technologies, Tersus Power enter into share exchange agreement - Global Technologies is pleased to inform shareholders that it has entered into a Definitive Share Exchange Agreement with Tersus Power. As previously announced on November 17, 2021, the Company entered into a Letter of Intent to acquire Tersus Power. On March 9, 2022, the Company entered into a Share Exchange Agreement with Tersus Power and the Tersus Shareholders. Under the terms of the Exchange Agreement, at Closing the Company shall deliver to the Tersus Shareholders a to-be-determined pro-rata number of shares of the Company's Class A Common Stock for each one share of Tersus common stock held by the Tersus Shareholder. Such shares of the Company's Class A Common Stock shall collectively be referred to as the "Exchange Shares", and constitute 75% of the issued and outstanding shares of stock, of all classes, of the Company immediately following the Closing. Conditions precedent to the Closing shall require the Company to complete the following corporate actions: the Company will have completed a merger with and into its wholly owned subsidiary sufficient to change its name to "Tersus Power, Inc.", a Delaware corporation, with an authorized capital of 500 million shares of common stock, and 10 million shares of preferred stock, the Company will have completed, and FINRA will have recognized and effectuated, a reverse split of its common stock in a range between 1-for-1,000 and 1-for-4,000, at a level that is acceptable to the Parties, all of the holders of the Company's Series K Preferred Stock and Series L Preferred Stock will have converted their preferred shares into Class A Common Stock of the Company, and certain nominees by the Tersus Shareholders shall be appointed to the Company's Board of Directors. Unless the Exchange Agreement shall have been terminated and the transactions therein contemplated shall have been abandoned, the closing of the Exchange will take place at 5:00 p.m. Pacific Time on the second business day following the satisfaction or waiver of the conditions. Either party may terminate the Exchange Agreement if a Closing has not occurred on or before June 30, 2022.

08:12 EST Huntington Ingalls names Harris chief sustainability and compliance officer - HII announced that Paul Harris has been appointed executive vice president and chief sustainability and compliance officer, reporting directly to HII President and CEO Chris Kastner on matters of sustainability. The move expands the scope of responsibilities for Harris, who has served as HII's chief compliance officer since 2020. "In his new role he will oversee the company's ongoing efforts to formalize and mature its strategy-driven environmental, social and governance program, in addition to overseeing matters of compliance," the company said.

08:11 EST Synthetic Biologics completes acquisition of VCN Biosciences - Synthetic Biologics announced that it has completed the acquisition of VCN Biosciences following the satisfaction of all closing conditions. "The acquisition of VCN positions us at the forefront of oncolytic virus development and propels the Synthetic Biologics pipeline forward," said Steven Shallcross, Chief Executive Officer of Synthetic Biologics. "The therapeutic application of OVs has been limited, in part, by a need for local administration. Our OVs are designed for systemic administration to target primary as well as metastatic tumors. Once inside the tumor, our OVs are uniquely engineered to replicate selectively and aggressively within the tumor cells and to break down the tumor stroma through the expression of PH20, a differentiating benefit of VCN-01." As consideration for the purchase of VCN, at the closing of the transaction Synthetic Biologics paid $4,700,000 to Grifols Innovation and New Technologies Limited, the owner of approximately 86% of the equity of VCN, and issued to the remaining shareholders and certain key employees and consultants of VCN 26,395,303 shares of common stock of Synthetic Biologics, representing 19.99% of the outstanding shares of Synthetic's Biologics common stock on December 14, 2021, the date of the Share Purchase Agreement with VCN and its shareholders. Synthetic Biologics has also agreed to make the following milestone payments to Grifols Innovation and New Technologies Limited: $3M upon VCN-01 US IND Safe to Proceed - PDAC; $2.75M upon VCN-01 US IND Safe to Proceed - RN; $3.25M upon VCN-01 US first patient dosed- PDAC after receipt of VCN-01 US IND Safe to Proceed for PDAC being informed; $3.25M upon VCN-01 US first patient dosed - RB after receipt of VCN-01 US IND Safe to Proceed for RB being informed; $6M upon VCN-01 US Phase 2 trial meets the primary endpoint or if a Phase 2 trial is not conducted and only a Phase 3 trial is conducted then upon a Phase 3 being initiated - PDAC; $8M upon VCN-01 Pivotal Trial meeting the primary endpoint or upon BLA Submission - RB; $12M upon VCN-01 US Phase 3 trial meeting the primary endpoint or upon BLA Submission - PDAC; $16M upon VCN-01 BLA Approval - PDAC; $16M upon VCN-01 BLA Approval - RB

08:08 EST American Resources acquires rights to PCI carbon surface mine - American Resources announced that it has acquired the operating rights to a PCI carbon surface mine operation to further expand the production of their McCoy Elkhorn Complex in Pike County, Kentucky. Once ramped, the Company anticipates the operation to produce between 5,000 to 15,000 tons per month. While the terms of the transaction were not disclosed there was no capital paid upfront as part of the transaction.

08:07 EST Achieve Life expands Manufacturing, Quality Operations team, inducement award - Achieve Life Sciences announced that the company has expanded its Manufacturing and Quality Operations Team with the hiring of a Vice President of Process Control and Quality Assurance. Achieve's Board of Directors approved the new employment inducement grant of stock options to purchase 20,000 shares of Achieve's common stock with a grant date of March 8, 2022. Achieve granted the stock options as a material inducement to the new employee for entering into employment agreements with Achieve in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options approved under the inducement grant were issued pursuant to a stock option agreement on terms substantially similar to Achieve's 2018 Equity Incentive Plan and have a per share exercise equal to the closing price of Achieve's common stock on March 8, 2022. The stock options have a 10-year term and are subject to the terms and conditions of the stock option agreement.

08:06 EST Capstone Green Energy to provide microturbine for gas-to-energy project - Capstone Green Energy announced that its distributor for the Upper Midwest, New England and Eastern Canada Vergent Power Solutions, has secured a contract to provide a one-megawatt microturbine system to be installed in a landfill gas-to-energy project for a solid waste facility in New England. The renewable energy project will convert the gas generated by waste at the landfill to electricity that will be redistributed to the electrical grid and utilized by the city to power its municipal facilities. The waste to energy project is expected to be commissioned in early 2023.

08:06 EST Conformis announces Gary Fischetti nominated to board of directors - Conformis announced that Gary Fischetti has been nominated to stand for election to the Company's Board of Directors at the Company's 2022 Annual Meeting of Stockholders, scheduled to be held on May 4, 2022. Fischetti will replace Richard Meelia, who will be retiring from the Board immediately prior to the Annual Meeting. Fischetti currently serves as the Chairman of the Board for Orchid Orthopedic Solutions and as a member of the Board at Extremity Medical.

08:04 EST Immunome announces FDA lifts clinical hold on IMM-BCP-01 IND application - Immunome announced that the FDA has lifted the clinical hold on its investigational new drug, or IND, application for its antibody cocktail, or IMM-BCP-01, for the treatment of SARS-CoV-2, or COVID-19. Immunome previously announced that the FDA had placed the company's IND application on clinical hold due to a request for further information related to the preparation and administration of IMM-BCP-01 at clinical sites. In response, Immunome provided the FDA with a comprehensive report detailing the necessary information.

08:02 EST Hoth Therapeutics: FDA Orphan Drug Designation granted to HT-KIT - Hoth Therapeutics announced the U.S. FDA designated HT-KIT, a new molecular entity, as an Orphan Drug for the treatment of mastocytosis. HT-KIT is an antisense oligonucleotide that targets the proto-oncogene cKIT by inducing mRNA frame shifting. Preclinical studies have demonstrated that HT-KIT induces apoptosis of neoplastic mast cells and reduces metastasis associated with aggressive mastocytosis.

07:51 EST Equifax partners with Team Velocity on subscription marketing service - Equifax and Team Velocity Marketing have partnered to deliver an innovative new subscription marketing service for automotive dealers through Team Velocity's recently launched Qualified Customer offering. Using anonymized Equifax differentiated data assets, Team Velocity has developed a proprietary propensity score to identify and target "perfect-time" shoppers - the individuals who are credit-qualified and most likely to buy a vehicle now.

07:40 EST Natera achieves milestone in its BESPOKE CRC study - Natera announced a milestone with over 100 sites initiated and 1,000 patients enrolled across the U.S. in its BESPOKE CRC study, a prospective, multi-center trial to measure the clinical impact of serial testing with Signatera in resectable CRC. Since its initial launch in January 2020, interest in the outcome of this trial has grown among oncologists nationwide, with a current target to enroll over 2,000 CRC patients across different stages of disease and to follow them for up to 5 years post surgery. The primary objectives of the study are to quantify the real-world impact of Signatera testing on both adjuvant treatment decisions and clinical outcomes, compared to a historical control group. The investigators plan to conduct an interim analysis later in 2022, for presentation at a future scientific congress.

07:34 EST Inspired Entertainment expects to file Form 12b-25 with SEC - The company expects to file a notification of late filing on Form 12b-25 with the SEC which provides an automatic 15-day extension of the filing deadline for its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 to March 31, 2022. The financial data presented for the year ended December 31, 2021 should be considered preliminary and could be subject to change as the company's independent registered public accounting firm has not completed its audit. The company anticipates that the Form 10-K for the year ended December 31, 2021 will be filed by March 31, 2022 or as soon as practicable.

07:33 EST Applied Materials announces new $6B share repurchase authorization - Applied Materials announced that its Board of Directors has approved a new $6B share repurchase authorization, supplementing the previous authorization which had $3.2B remaining at the end of the first quarter of fiscal 2022. "The new share repurchase authorization and dividend increase demonstrate Applied Materials' confidence in the long-term growth of our markets, the strength of our technology, and our ability to generate strong cash flow and attractive shareholder returns," said Gary Dickerson, President and CEO. "Our broad portfolio of innovative products puts Applied in a great position to outperform our markets in the years ahead."

07:24 EST EP Group announces EPI Health acquisition by Novan - The EP Group announced the acquisition of EPI Health, by Novan. Novan will host a conference call and webcast, March 11, 2022, at 8:30 a.m. ET. The company said, "EPI Health is an established specialty dermatology company that markets innovative prescription therapies to dermatologists to improve patients' quality of life. It is one of the leading companies in the US dermatology sector. EPI Health has an established sales force and commercial team with existing, deep market relationships across the dermatology community...Novan is a specialty dermatology pharmaceutical company focused on developing therapeutic products for skin diseases. The Company is leveraging its core platform of nitric oxide-based science and clinical translation expertise to bring new medicines to market. Novan announced positive results in a Phase 3 study from its lead candidate berdazimer gel 10.3% for the treatment of molluscum contagiosum and is advancing to submit a New Drug Application with the U.S. Food and Drug Administration targeted in Q4 2022." Following the acquisition, the Company will employ approximately 100 staff with over 300 years of experience in dermatology product development, commercialization, and sales.

07:18 EST Guardforce to expand Robotics as a Service to China's greater Bay Area - Guardforce announced the signing of the definitive agreement of the previously proposed acquisition of Shenzhen Keweien Robot Service and Guangzhou Kewei Robot Technology. This acquisition is expected to serve an integral role in the growth of Guardforce AI's robotics as a service business initiative. This acquisition is expected to be closed by end of April. The acquisition purchase price of $10M will be paid in a mix of cash and restricted ordinary shares of the company. Guardforce AI is presently listed on the U.S. Nasdaq Capital Market under the symbol "GFAI." For purposes of the definitive acquisition agreement, each share will be valued at $4.20. SZ and GZ are based in the Greater Bay Area, one of the fastest-growing economic regions in China with both Shenzhen and Guangzhou ranking among the top 10 largest Chinese cities and among the 30 largest cities globally. Focused on the hospitality, healthcare, property management, and government sectors, SZ and GZ derive revenues from AI robotic services which automate repetitive tasks, making them less labor intensive.

07:15 EST Oxford Biomedica launches Oxford Biomedica Solutions business - Oxford Biomedica (OXBDF) is pleased to announce that it has completed its deal with Homology Medicines Inc. (FIXX), to establish Oxford Biomedica Solutions LLC, a new US-based full scope, Adeno-Associated Virus manufacturing and innovation business. The new Oxford Biomedica Solutions business is fully operational and offers a proprietary 'plug and play' platform that is capable of achieving both high titre and high product quality vector for customers. The platform has already been proven with three separate new product INDs, and the process has been run successfully at representative scale more than 600 times. High titre, high product quality, proven expertise, and speed are the foundation of the platform, and this differentiated new offering. The platform and fully integrated end-to-end capabilities, including from vector design and process development through to clinical trials, are now available to customers. This includes: Proprietary 'plug and play' process and manufacturing platform protected by intellectual property; Team of approx.125 with complete end to end AAV expertise and experience; 45+ successful 500L cGMP batches produced since 2019; 3 x 500L single use bioreactors in multiple GMP suites operational; Full CMC development scope: vector design, plasmid engineering, upstream, downstream, analytical development, formulation development; cGMP operations scope: Manufacturing, engineering, quality assurance, quality control, warehousing; Platform successfully scaled to 2,000L; Platform is a consistent and reliable serum free suspension cell culture and transfections system, and a two-column chromatography purification.

07:13 EST Communications Systems provides insight to proposed Pineapple Energy merger - Communications Systems provided additional insight into the strategic alternatives process that led to the proposed merger with Pineapple Energy that will deliver value to CSI shareholders if the proposed merger is approved at the special meeting of CSI shareholders scheduled for March 16. The company said, "The CSI board of directors has unanimously approved the proposed merger and recommends that CSI shareholders vote FOR the merger proposal and all other proposals. The special committee of the CSI board of directors, consisting solely of independent directors including two board members identified by the Company's two largest shareholders, also unanimously approved the proposed merger. The merger is the result of strategic alternatives process that was publicly announced in May 2018. The CSI board of directors continues to believe that the merger with Pineapple is more likely to deliver a more favorable and attractive value and return to the CSI shareholders than the potential value or return that might result from other possible strategic alternatives, including continued operation of CSI's S&S segment businesses, the development and execution of a transformative plan for CSI, or a complete liquidation of CSI. As previously described, the CVR will be distributed to pre-merger CSI shareholders as part of the CSI board's strategy to deliver value to the CSI shareholders from CSI's legacy assets. Following the closing of the merger, CSI will distribute its legacy cash to CVR holders in accordance with the CVR agreement as soon as August 2022. CSI's cash was approximately $6.4 million at December 31, 2021 and CSI's legacy cash at the closing of the merger will be increased by an estimated $3.44 million as a reimbursement of expenses associated with the merger transaction. Additionally, CSI currently is targeting to close the sale of its Minnetonka headquarters in April 2022. The net proceeds from an April 2022 sale of the Minnetonka headquarters, after escrows and holdbacks required by the CVR agreement, would be available for distribution to the CVR holders also as soon as August 2022. Therefore, the CSI board of directors is confident that CSI shareholders will realize value from the CSI legacy assets in 2022 in addition to the 2021 special dividend of $3.50 per share. Also, receipt of the CVR and receipt of cash distributions by CVR holders will occur in the same tax year. However, if the CSI shareholders do not approve the merger with Pineapple, CSI will be responsible for its transaction related expenses and none of estimated $3.44 million in expenses will be reimbursed to CSI. Additionally, CSI will continue to incur costs to operate its S&S segment business and comply with its public company reporting obligations until the CSI board of directors implements one or more strategic alternatives if the CSI shareholders do not approve the merger with Pineapple. These costs and expenses, along with the expense associated with implementing one or more strategic alternatives, will reduce CSI's cash available for any future strategic alternative, including for distribution to CSI shareholders in liquidation if that strategic alternative is approved by the CSI board of directors. If the merger is not approved by CSI shareholders, the range of strategic alternatives available to the CSI board of directors also may be limited. The merger with Pineapple is the culmination of a multi-year strategic alternatives process, and was determined by the CSI board of directors to be in the best interests of the CSI shareholders. The merger was publicly announced in March 2021 and since that time, no alternative bidder has announced any interest in acquiring CSI. Additionally, if the merger is not approved by CSI shareholders, there is no assurance that CSI would be able to identify any other private company interested in a similar reverse merger transaction or that such a transaction would result in comparable value to the CSI shareholders as the merger with Pineapple, particularly when taking into account the value to the CSI shareholders of the CVRs. In particular, CSI will face competition from SPACs and other public companies to attract a private company for a similar reverse merger transaction and these SPACs and other public companies may offer cash resources, access to financing or transaction terms that would be more favorable that what CSI could offer. Additionally, if the merger with Pineapple is not approved by CSI shareholders despite the unanimous recommendation of the CSI board of directors that CSI shareholders vote FOR the merger with Pineapple, CSI's ability to attract another private company for a similar reverse merger transaction will be significantly hampered by the perception that CSI shareholders would not support a similar reverse merger transaction, which would also require CSI shareholder approval."

07:12 EST ACM Research comments on SEC announcements on U.S. HFCAA - ACM Research commented on recent announcements made by the U.S. Securities and Exchange Commission regarding the U.S. Holding Foreign Companies Accountable Act of 2020. On March 8, 2022, the SEC published its first "Provisional list of issuers identified under the HFCAA." ACM was identified on the SEC's provisional list after ACM filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which includes an audit report issued by a public accounting firm that the PCAOB is unable to inspect because of regulations in China. ACM appeared relatively early on the SEC's provisional list after the filing of its Annual Report on Form 10-K on March 1, 2022. ACM anticipates additional companies with relatively later filing schedules will appear on subsequent provisional lists as those companies file their respective annual reports. ACM's appearance on the provisional list does not mean ACM will be delisted soon, or at all. According to SEC guidelines, the earliest a trading prohibition could be invoked is 2024, once an issuer has appeared on the SEC's provisional lists for three consecutive years, 2022, 2023 and 2024. Moreover, ACM is implementing plans to identify and appoint an independent public accounting firm that is subject to inspection by the PCAOB, in order that in the future ACM will no longer appear on the SEC's provisional lists and will no longer be subject to the related delisting guidelines. "ACM has already begun to interview potential U.S. auditors to comply with the guidelines," said Dr. David Wang, President and CEO of ACM. "As we announced on December 7, 2021, we are confident in our ability to meet the SEC requirements in advance of the 2024 deadline, and we remain committed to our NASDAQ listing status."

07:10 EST Brady announces CEO leadership transition - Brady announced the retirement of Director, President and Chief Executive Officer Michael Nauman and the appointment of current Senior Vice President and President - Identification Solutions, Russell Shaller as President, Chief Executive Officer and Director, effective April 1, 2022. At the request of the Board of Directors, Nauman will remain with the Company in a consultative position until June 17, 2022, to ensure a smooth transition. Shaller will retain his responsibilities as Senior Vice President and President - Identification Solutions while conducting a search for his replacement. Shaller has served as Brady's Senior Vice President and President - Identification Solutions for nearly 7 years.

07:08 EST Clene provides update on upcoming trial results - CNM-Au8 for the treatment of amyotrophic lateral sclerosis: Healey ALS Platform Trial top-line data expected 2H 202. CNM-Au8 for the treatment of multiple sclerosis: The VISIONARY-MS Phase 2 clinical trial will conclude early due to pandemic-related enrollment challenges. Clene will utilize the available data collected from up to 48 weeks of clinical visits to better understand the efficacy and safety profile of CNM-Au8 and to inform further clinical development in MS. Unblinded VISIONARY-MS data are targeted for the second half of 2022. CNM-ZnAg for the treatment of COVID-19: The CNM-ZnAg COVID Phase 2 clinical trial achieved full enrollment in acutely symptomatic, non-hospitalized COVID-19 patients in Brazil. Top-line results are expected mid-year 2022.

07:06 EST Real Good Food sees long-term net sales of $500M - Sees long-term Adjusted gross margin of 35%; Adjusted EBITDA margin of 15%.

07:05 EST Clene see cash funding operations into Q2 of 2023 - Clene's cash and restricted cash totaled $50.3 million as of December 31, 2021, compared to $59.3 million as of December 31, 2020. Clene expects that its resources as of December 31, 2021, will be sufficient to fund its operations into the second quarter of 2023.

06:48 EST MAG Silver to acquire Gatling Exploration in an all-share transaction - MAG Silver is pleased to announce that it has entered into a Definitive Arrangement Agreement with Gatling Exploration pursuant to which MAG will acquire all of the issued and outstanding common shares of Gatling in an all-share transaction. Each Gatling shareholder will be entitled to receive 0.01702627 of a common share of MAG for each share of Gatling held. The Consideration values Gatling at approximately C$0.40 per share, representing a premium of approximately 47.4% to Gatling shareholders, based on the 5-day volume weighted average price of each company as of the close of trading on March 10. Upon completion of the Transaction, it is expected that Gatling shareholders will hold approximately 0.79% of MAG shares on an outstanding basis. Transaction is subject to the receipt of applicable regulatory approvals, including approval of the TSX, and the satisfaction of certain other closing conditions customary in transactions of this nature and is anticipated to be completed by late May.

06:37 EST Novan acquires EPI Health for $27.5M upfront - Novan announced its acquisition of EPI Health, a specialty pharmaceutical company focused on the U.S. dermatology market. Under the terms of the transaction, Novan has acquired EPI Health for an upfront purchase price of $27.5M, consisting of $11M in cash and $16.5M in a seller's note with a 24-month term. Based on financial performance of EPI's products and the occurrence of other events, Novan will pay up to an additional $23.5M in potential future milestone payments, certain of which may be paid in cash or in shares of Novan common stock at Novan's discretion.

06:35 EST Emergent BioSolutions initiates Phase 1 study of SIAN - Emergent BioSolutions announced that it has dosed the first participant in its Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite, a treatment being developed for known or suspected acute cyanide poisoning. Under an existing multi-year contract with the Biomedical Advanced Research and Development Authority, and in collaboration with the Southwest Research Institute, Emergent is developing a single-use intranasal spray intended for administration by first responders and medical personnel following a cyanide incident.

06:32 EST Taconic, HEI to acquire Westchester Marriott from Ares Commercial for $40M - Taconic Capital Advisors, HEI Hotels & Resorts and Ares Commercial Real Estate announced that Taconic and HEI have partnered to acquire the Westchester Marriott, a 444-key hotel in Tarrytown, NY, from ACRE for $40M. As part of the transaction, ACRE has elected to provide a financing facility in support of the business plan for the hotel property. The 15-acre property, located at 670 White Plains Road in Tarrytown, offers 21 event rooms for a total of 26,700 square feet of conference and meeting space, including a 9,000-square foot ballroom with a total capacity of 1,100 people. The property includes a Ruth's Chris Steak House, Cooper Mill American restaurant, a gift shop, fitness center, spa and laundry. The hotel will continue to operate under the Marriott flag and will be managed by HEI Hotels & Resorts. Taconic and HEI will execute a comprehensive $30M case and soft goods renovation focused on all areas of the hotel. The Westchester market has lost nearly 1,200 directly competitive hotel rooms during the last several years, including more than 90,000 square feet of meeting space.

06:10 EST Park Hotels & Resorts reports preliminary February pro-forma occupancy 52.8% - Up 12.8 pts vs. January. Reports preliminary February pro-forma ADR $223.63, up 9.2% vs. January; pro-forma RevPAR $118.07, up 44.3% vs. January.

06:06 EST Dada Nexus announces $70M share repurchase program - Dada Nexus announced that the board of directors of the company has authorized a share repurchase program whereby Dada is authorized to repurchase its own ordinary shares in the form of American depository shares with an aggregate value of up to $70M during the next 12-month period. The company expects to fund the repurchase out of its existing cash balance.

06:03 EST China Yuchai to power 800 Ankai buses - China Yuchai announced that GYMCL's YC6GN natural gas engines became the exclusive engine to power 800 Ankai buses that were recently shipped to Mexico. These new Yuchai-powered Ankai buses will operate in Monterrey, Mexico, which is the third largest city in Mexico. With the continuous growth of its urban population, Monterrey is replacing its traditional energy city buses to provide a more environmentally friendly travel solution. Monterrey is also an important industrial and business hub with a number of large Mexican and international companies operating there. Prior to this, YC6GN gas engines were already in city bus operations in Mexico, including the Chihuahua Prefecture, and the performance of the engines has been well received by the local transportation department and bus operators. Designed for on-road applications, the YC6GN is a 7.8-liter heavy-duty engine powered by 6 cylinders and delivers up to 191 horsepower to propel buses up to 12 meters in length. YC6GN also provides "green energy" solutions in compliance with the Euro V and Chinese National-V emission standards.

05:38 EST CMA opens investigation into anti-competitive agreement between Google, Meta - On March 10, the U.K.'s CMA launched an investigation under Chapter I and Chapter II of the Competition Act 1998 into suspected breaches of competition law by Google (GOOGL) and Meta (FB). The investigation concerns an agreement between Google and Meta in relation to Meta's use of Google's header bidding product, the CMA said. The CMA is also investigating whether Google's conduct may have affected the ability of other firms to compete with its header bidding product. The CMA has not reached a view as to whether there is sufficient evidence of an infringement or infringements of competition law for it to issue a statement of objections to any party under investigation. Reference Link

05:18 EST Hutchmed gives update on status under Holding Foreign Companies Accountable Act - Hutchmed provided an update on its status under the Holding Foreign Companies Accountable Act. The company said, "On March 8, 2022, as expected in its implementation of the Act, the U.S. Securities and Exchange Commission (the "SEC") provisionally named the Company as a Commission-Identified Issuer, following the Company's filing of its annual report on Form 20-F with the SEC on March 3, 2022. The SEC estimated that 273 registrants might be identified under the Act as part of its review of registrants in calendar year 2020. We anticipate that other similarly situated U.S.-listed companies with operations in Hong Kong and other parts of China will be added once they file their annual reports with the SEC. The Act is part of a continued regulatory focus in the United States on access to audit and other information currently protected by national law, in particular China's, and the preparation of such list is provided for in the Act and the SEC's implementing rules. The Act requires the SEC to prohibit the securities of any "covered issuer," including the Company, from being traded on any of the U.S. securities exchanges, including the Nasdaq Stock Market, if the auditor of the covered issuer's financial statements is not subject to inspection by the U.S. Public Company Accounting Oversight Board ("PCAOB") for three consecutive years, beginning in 2021. Under the current terms of the Act, the Company's American depositary shares will be delisted from the Nasdaq Stock Market in early 2024, unless the Act is amended to exclude the Company or the PCAOB is able to conduct a full inspection of the Company's auditor during the required timeframe. In addition, legislation is being considered in the United States to shorten the number of non-inspection years from three years to two. The Company's American depositary shares, each of which represents five ordinary shares, trade on the Nasdaq Global Select Market and its ordinary shares are admitted for trading on the AIM market. In addition, on June 30, 2021, the Company completed a primary listing of its ordinary shares on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX") under the stock code "0013". The shares listed on HKEX and AIM are fully fungible with the shares represented by the Company's American depositary shares. The Company will continue to monitor market developments and evaluate all strategic options."

05:12 EST Philips announces Collaboration Live receives additional FDA clearance - Philips announced that Collaboration Live has received expansion of its FDA 510(k) market clearance for remote diagnostic use on additional mobile platforms. Available on Philips Ultrasound Systems EPIQ and Affiniti, Collaboration Live allows clinicians to collaborate in real-time with colleagues in order to complete image acquisition and diagnosis regardless of location.